Abstract
The human genome project and subsequent deluge of various high-throughput data in all aspects of molecular biology has not only augmented our knowledge at a breakneck speed but also shifted thinking paradigms about understanding and management of human health and disease. Whole genome sequencing is quickly becoming the first step of disease management particularly in the case of cancer. In this chapter, we have discussed recent advancement in the knowledge in cancer biology through genomic approaches – with a focus on signalling pathways.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Achinger-Kawecka J, Clark SJ (2017) Disruption of the 3D cancer genome blueprint. Epigenomics 9(1):47–55. https://doi.org/10.2217/epi-2016-0111
Achinger-Kawecka J, Taberlay PC, Clark SJ (2016) Alterations in three-dimensional organization of the cancer genome and epigenome. Cold Spring Harb Symp Quant Biol 81:41–51. https://doi.org/10.1101/sqb.2016.81.031013
Adey A, Morrison HG, Asan XX, Kitzman JO, Turner EH et al (2010) Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol 11(12):R119. https://doi.org/10.1186/gb-2010-11-12-r119
Ahn SH, Henderson KA, Keeney S, Allis CD (2005) H2B (Ser10) phosphorylation is induced during apoptosis and meiosis in S. cerevisiae. Cell Cycle 4(6):780–783. https://doi.org/10.4161/cc.4.6.1745
Alon S, Mor E, Vigneault F, Church GM, Locatelli F, Galeano F et al (2012) Systematic identification of edited microRNAs in the human brain. Genome Res 22(8):1533–1540. https://doi.org/10.1101/gr.131573.111
Alwine JC, Kemp DJ, Stark GR (1977) Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A 74(12):5350–5354
Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27(15):2128–2136. https://doi.org/10.1038/sj.onc.1210856
Athanasiadis A, Rich A, Maas S (2004) Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol 2(12):e391. https://doi.org/10.1371/journal.pbio.0020391
Babu D, Fullwood MJ (2015) 3D genome organization in health and disease: emerging opportunities in cancer translational medicine. Nucleus 6(5):382–393. https://doi.org/10.1080/19491034.2015.1106676
Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21(3):381–395. https://doi.org/10.1038/cr.2011.22
Barlesi F, Giaccone G, Gallegos-Ruiz MI, Loundou A, Span SW, Lefesvre P et al (2007) Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol 25(28):4358–4364. https://doi.org/10.1200/JCO.2007.11.2599
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Barutcu AR, Hong D, Lajoie BR, McCord RP, van Wijnen AJ, Lian JB et al (2016) RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. Biochim Biophys Acta 1859(11):1389–1397. https://doi.org/10.1016/j.bbagrm.2016.08.003
Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11(10):726–734. https://doi.org/10.1038/nrc3130
Bechara EG, Sebestyen E, Bernardis I, Eyras E, Valcarcel J (2013) RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol Cell 52(5):720–733. https://doi.org/10.1016/j.molcel.2013.11.010
Benne R, Van den Burg J, Brakenhoff JP, Sloof P, Van Boom JH, Tromp MC (1986) Major transcript of the frameshifted coxII gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA. Cell 46(6):819–826
Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY et al (2011) The genomic complexity of primary human prostate cancer. Nature 470(7333):214–220. https://doi.org/10.1038/nature09744
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J et al (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2):315–326. https://doi.org/10.1016/j.cell.2006.02.041
Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Cervera N, Tarpin C et al (2005) Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 65(6):2170–2178. https://doi.org/10.1158/0008-5472.CAN-04-4115
Bestor TH (1988) Cloning of a mammalian DNA methyltransferase. Gene 74(1):9–12
Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321(6067):209–213. https://doi.org/10.1038/321209a0
Bolzer A, Kreth G, Solovei I, Koehler D, Saracoglu K, Fauth C et al (2005) Three-dimensional maps of all chromosomes in human male fibroblast nuclei and prometaphase rosettes. PLoS Biol 3(5):e157. https://doi.org/10.1371/journal.pbio.0030157
Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z et al (2008) High-resolution mapping and characterization of open chromatin across the genome. Cell 132(2):311–322. https://doi.org/10.1016/j.cell.2007.12.014
Briggs SD, Xiao T, Sun ZW, Caldwell JA, Shabanowitz J, Hunt DF et al (2002) Gene silencing: trans-histone regulatory pathway in chromatin. Nature 418(6897):498. https://doi.org/10.1038/nature00970
Brownell JE, Allis CD (1995) An activity gel assay detects a single, catalytically active histone acetyltransferase subunit in Tetrahymena macronuclei. Proc Natl Acad Sci U S A 92(14):6364–6368
Buck MJ, Raaijmakers LM, Ramakrishnan S, Wang D, Valiyaparambil S, Liu S et al (2014) Alterations in chromatin accessibility and DNA methylation in clear cell renal cell carcinoma. Oncogene 33(41):4961–4965. https://doi.org/10.1038/onc.2013.455
Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ (2013) Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10(12):1213–1218. https://doi.org/10.1038/nmeth.2688
Cacheux W, Dangles-Marie V, Rouleau E, Lazartigues J, Girard E, Briaux A et al (2018) Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma. Oncotarget 9(1):464–476. https://doi.org/10.18632/oncotarget.23066
Cai X, Evrony GD, Lehmann HS, Elhosary PC, Mehta BK, Poduri A, Walsh CA (2015) Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep 10(4):645. https://doi.org/10.1016/j.celrep.2015.01.028
Cancer Genome Atlas Research, N (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499(7456):43–49. https://doi.org/10.1038/nature12222
Carmi S, Borukhov I, Levanon EY (2011) Identification of widespread ultra-edited human RNAs. PLoS Genet 7(10):e1002317. https://doi.org/10.1371/journal.pgen.1002317
Cesarini V, Silvestris DA, Tassinari V, Tomaselli S, Alon S, Eisenberg E et al (2018) ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion. Nucleic Acids Res 46(4):2045–2059. https://doi.org/10.1093/nar/gkx1257
Chakravarthi BV, Nepal S, Varambally S (2016) Genomic and epigenomic alterations in cancer. Am J Pathol 186(7):1724–1735. https://doi.org/10.1016/j.ajpath.2016.02.023
Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033. https://doi.org/10.1158/0008-5472.CAN-05-0137
Chandran UR, Luthra S, Santana-Santos L, Mao P, Kim SH, Minata M et al (2015) Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells. Genom Data 5:333–336. https://doi.org/10.1016/j.gdata.2015.07.007
Chang B, Chen Y, Zhao Y, Bruick RK (2007) JMJD6 is a histone arginine demethylase. Science 318(5849):444–447. https://doi.org/10.1126/science.1145801
Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R et al (2012) Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148(6):1293–1307. https://doi.org/10.1016/j.cell.2012.02.009
Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y et al (2013) Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 19(2):209–216. https://doi.org/10.1038/nm.3043
Chervona Y, Costa M (2012) Histone modifications and cancer: biomarkers of prognosis? Am J Cancer Res 2(5):589–597
Chomet PS (1991) Cytosine methylation in gene-silencing mechanisms. Curr Opin Cell Biol 3(3):438–443
Choudhury Y, Tay FC, Lam DH, Sandanaraj E, Tang C, Ang BT, Wang S (2012) Attenuated adenosine-to-inosine editing of microRNA-376a∗ promotes invasiveness of glioblastoma cells. J Clin Invest 122(11):4059–4076. https://doi.org/10.1172/JCI62925
Chrun ES, Modolo F, Daniel FI (2017) Histone modifications: a review about the presence of this epigenetic phenomenon in carcinogenesis. Pathol Res Pract 213(11):1329–1339. https://doi.org/10.1016/j.prp.2017.06.013
Climente-Gonzalez H, Porta-Pardo E, Godzik A, Eyras E (2017) The functional impact of alternative splicing in cancer. Cell Rep 20(9):2215–2226. https://doi.org/10.1016/j.celrep.2017.08.012
Collet-Cassart D, Van den Abbeele E, Poncelet S (1989) A quantitative C-reactive protein assay using latex agglutination in microtiter plates. J Immunol Methods 125(1–2):137–141
Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, Landa I, Leandro-Garcia LJ, Leton R et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43(7):663–667. https://doi.org/10.1038/ng.861
Consortium, E. P (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57–74. https://doi.org/10.1038/nature11247
Costello JF, Plass C (2001) Methylation matters. J Med Genet 38(5):285–303
Cousins DJ, Islam SA, Sanderson MR, Proykova YG, Crane-Robinson C, Staynov DZ (2004) Redefinition of the cleavage sites of DNase I on the nucleosome core particle. J Mol Biol 335(5):1199–1211
Cowper-Sal lari R, Zhang X, Wright JB, Bailey SD, Cole MD, Eeckhoute J et al (2012) Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 44(11):1191–1198. https://doi.org/10.1038/ng.2416
Cremer T, Cremer C (2001) Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet 2(4):292–301. https://doi.org/10.1038/35066075
Cremer T, Cremer C, Baumann H, Luedtke EK, Sperling K, Teuber V, Zorn C (1982) Rabl’s model of the interphase chromosome arrangement tested in Chinese hamster cells by premature chromosome condensation and laser-UV-microbeam experiments. Hum Genet 60(1):46–56
Cremer T, Cremer M, Dietzel S, Muller S, Solovei I, Fakan S (2006) Chromosome territories–a functional nuclear landscape. Curr Opin Cell Biol 18(3):307–316. https://doi.org/10.1016/j.ceb.2006.04.007
Cuddeback SM, Yamaguchi H, Komatsu K, Miyashita T, Yamada M, Wu C et al (2001) Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem 276(23):20559–20565. https://doi.org/10.1074/jbc.M101527200
Dang TP, Gazdar AF, Virmani AK, Sepetavec T, Hande KR, Minna JD et al (2000) Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst 92(16):1355–1357
Dardenne E, Pierredon S, Driouch K, Gratadou L, Lacroix-Triki M, Espinoza MP et al (2012) Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness. Nat Struct Mol Biol 19(11):1139–1146. https://doi.org/10.1038/nsmb.2390
Dawar S, Shahrin NH, Sladojevic N, D'Andrea RJ, Dorstyn L, Hiwase DK, Kumar S (2016) Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice. Cell Death Dis 7(12):e2509. https://doi.org/10.1038/cddis.2016.406
Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150(1):12–27. https://doi.org/10.1016/j.cell.2012.06.013
Dekker J, Rippe K, Dekker M, Kleckner N (2002) Capturing chromosome conformation. Science 295(5558):1306–1311. https://doi.org/10.1126/science.1067799
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K et al (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412(6849):822–826. https://doi.org/10.1038/35090585
Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y et al (2012) Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485(7398):376–380. https://doi.org/10.1038/nature11082
Doerfler W, Hoeveler A, Weisshaar B, Dobrzanski P, Knebel D, Langner KD et al (1989) Promoter inactivation or inhibition by sequence-specific methylation and mechanisms of reactivation. Cell Biophys 15(1–2):21–27
Dostie J, Richmond TA, Arnaout RA, Selzer RR, Lee WL, Honan TA et al (2006) Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res 16(10):1299–1309. https://doi.org/10.1101/gr.5571506
Dreazen O, Klisak I, Jones G, Ho WG, Sparkes RS, Gale RP (1987) Multiple molecular abnormalities in Ph1 chromosome positive acute lymphoblastic leukaemia. Br J Haematol 67(3):319–324
Dryden NH, Broome LR, Dudbridge F, Johnson N, Orr N, Schoenfelder S et al (2014) Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C. Genome Res 24(11):1854–1868. https://doi.org/10.1101/gr.175034.114
Dufva O, Kankainen M, Kelkka T, Sekiguchi N, Awad SA, Eldfors S et al (2018) Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nat Commun 9(1):1567. https://doi.org/10.1038/s41467-018-03987-2
Eberwine J, Sul JY, Bartfai T, Kim J (2014) The promise of single-cell sequencing. Nat Methods 11(1):25–27
Edwards JR, Yarychkivska O, Boulard M, Bestor TH (2017) DNA methylation and DNA methyltransferases. Epigenetics Chromatin 10:23. https://doi.org/10.1186/s13072-017-0130-8
Elemento O, Rubin MA, Rickman DS (2012) Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer. Cell Cycle 11(18):3380–3383. https://doi.org/10.4161/cc.21401
Ellinger J, Kahl P, von der Gathen J, Heukamp LC, Gutgemann I, Walter B et al (2012) Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Investig 30(2):92–97. https://doi.org/10.3109/07357907.2011.636117
Erinjeri NJ, Nicolson NG, Deyholos C, Korah R, Carling T (2018) Whole-exome sequencing identifies two discrete druggable signaling pathways in follicular thyroid cancer. J Am Coll Surg 226(6):950–959. e955. https://doi.org/10.1016/j.jamcollsurg.2018.01.059
Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21(35):5427–5440. https://doi.org/10.1038/sj.onc.1205600
Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4(2):143–153. https://doi.org/10.1038/nrc1279
Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301(5895):89–92
Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7(1):21–33. https://doi.org/10.1038/nrg1748
Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S et al (2009) MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69(14):5761–5767. https://doi.org/10.1158/0008-5472.CAN-08-4797
Forootan SS, Butler JM, Gardener D, Baird AE, Dodson A, Darby A et al (2016) Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications. Int J Oncol 48(1):130–144. https://doi.org/10.3892/ijo.2015.3222
Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM et al (2006) Copy number variation: new insights in genome diversity. Genome Res 16(8):949–961. https://doi.org/10.1101/gr.3677206
Fudenberg G, Getz G, Meyerson M, Mirny LA (2011) High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat Biotechnol 29(12):1109–1113. https://doi.org/10.1038/nbt.2049
Fujita M, Matsubara N, Matsuda I, Maejima K, Oosawa A, Yamano T et al (2018) Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling. Oncotarget 9(1):969–981. https://doi.org/10.18632/oncotarget.22867
Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB et al (2009) An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 462(7269):58–64. https://doi.org/10.1038/nature08497
Fullwood MJ, Han Y, Wei CL, Ruan X, Ruan Y (2010) Chromatin interaction analysis using paired-end tag sequencing. Curr Protoc Mol Biol,. Chapter 21 Unit 21(15):21–25. https://doi.org/10.1002/0471142727.mb2115s89
Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28(17):5369–5380. https://doi.org/10.1128/MCB.00479-08
Galamb O, Kalmar A, Peterfia B, Csabai I, Bodor A, Ribli D et al (2016) Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer. Epigenetics 11(8):588–602. https://doi.org/10.1080/15592294.2016.1190894
Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11(19):6883–6894
Gan Y, Li Y, Long Z, Lee AR, Xie N, Lovnicki JM et al (2018) Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer. EBioMedicine 31:267–275. https://doi.org/10.1016/j.ebiom.2018.05.002
Gary JD, Clarke S (1998) RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61:65–131
Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, Fogarty MP et al (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42(3):255–259. https://doi.org/10.1038/ng.530
Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD (2007) FAIRE (formaldehyde-assisted isolation of regulatory elements) isolates active regulatory elements from human chromatin. Genome Res 17(6):877–885. https://doi.org/10.1101/gr.5533506
Gonzalez A, Schachner LA, Cleary T, Scott G, Taplin D, Lambert W (1989) Pyoderma in childhood. Adv Dermatol 4:127–141. discussion 142
Goryshin IY, Reznikoff WS (1998) Tn5 in vitro transposition. J Biol Chem 273(13):7367–7374
Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG et al (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67(13):6092–6099. https://doi.org/10.1158/0008-5472.CAN-06-4607
Gronbaek K, Hother C, Jones PA (2007) Epigenetic changes in cancer. APMIS 115(10):1039–1059. https://doi.org/10.1111/j.1600-0463.2007.apm_636.xml.x
Groschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BAM, Erpelinck C et al (2014) A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 157(2):369–381. https://doi.org/10.1016/j.cell.2014.02.019
Grun D, Wang YL, Langenberger D, Gunsalus KC, Rajewsky N (2005) microRNA target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol 1(1):e13. https://doi.org/10.1371/journal.pcbi.0010013
Guo Y, Xu Q, Canzio D, Shou J, Li J, Gorkin DU et al (2015) CRISPR inversion of CTCF sites alters genome topology and enhancer/promoter function. Cell 162(4):900–910. https://doi.org/10.1016/j.cell.2015.07.038
Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127(4):679–695. https://doi.org/10.1016/j.cell.2006.11.001
Hagege H, Klous P, Braem C, Splinter E, Dekker J, Cathala G et al (2007) Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2(7):1722–1733. https://doi.org/10.1038/nprot.2007.243
Hake SB, Allis CD (2006) Histone H3 variants and their potential role in indexing mammalian genomes: the “H3 barcode hypothesis”. Proc Natl Acad Sci U S A 103(17):6428–6435. https://doi.org/10.1073/pnas.0600803103
Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Kim KY et al (2014) RNA editing in RHOQ promotes invasion potential in colorectal cancer. J Exp Med 211(4):613–621. https://doi.org/10.1084/jem.20132209
Han L, Diao L, Yu S, Xu X, Li J, Zhang R et al (2015) The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 28(4):515–528. https://doi.org/10.1016/j.ccell.2015.08.013
Hansen AS, Pustova I, Cattoglio C, Tjian R, Darzacq X (2017) CTCF and cohesin regulate chromatin loop stability with distinct dynamics. elife 6. https://doi.org/10.7554/eLife.25776
Hardt O, Wild S, Oerlecke I, Hofmann K, Luo S, Wiencek Y et al (2012) Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway. Cancer Lett 325(2):165–174. https://doi.org/10.1016/j.canlet.2012.06.010
He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q et al (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333(6047):1303–1307. https://doi.org/10.1126/science.1210944
He HH, Meyer CA, Hu SS, Chen MW, Zang C, Liu Y et al (2014) Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification. Nat Methods 11(1):73–78. https://doi.org/10.1038/nmeth.2762
Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD et al (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39(3):311–318. https://doi.org/10.1038/ng1966
Henikoff S, Ahmad K (2005) Assembly of variant histones into chromatin. Annu Rev Cell Dev Biol 21:133–153. https://doi.org/10.1146/annurev.cellbio.21.012704.133518
Hesketh R (2013) Introduction to cancer biology. Cambridge University Press, Cambridge, New York
Hesselberth JR, Chen X, Zhang Z, Sabo PJ, Sandstrom R, Reynolds AP et al (2009) Global mapping of protein-DNA interactions in vivo by digital genomic footprinting. Nat Methods 6(4):283–289. https://doi.org/10.1038/nmeth.1313
Higashimori A, Dong Y, Zhang Y, Kang W, Nakatsu G, Ng SSM et al (2018) Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-beta-catenin signaling axis. Cancer Res 78(7):1643–1656. https://doi.org/10.1158/0008-5472.CAN-17-2403
Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH (1993) RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75(7):1361–1370
Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N et al (2000) Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406(6791):78–81. https://doi.org/10.1038/35017558
Hoang PH, Dobbins SE, Cornish AJ, Chubb D, Law PJ, Kaiser M, Houlston RS (2018) Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms. Leukemia. https://doi.org/10.1038/s41375-018-0103-3
Hu H, Wang M, Wang H, Liu Z, Guan X, Yang R et al (2018) MEGF6 promotes the epithelial-to-mesenchymal transition via the TGFbeta/SMAD signaling pathway in colorectal cancer metastasis. Cell Physiol Biochem 46(5):1895–1906. https://doi.org/10.1159/000489374
Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA et al (2008) Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol 4:188. https://doi.org/10.1038/msb.2008.25
Hughes JR, Roberts N, McGowan S, Hay D, Giannoulatou E, Lynch M et al (2014) Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat Genet 46(2):205–212. https://doi.org/10.1038/ng.2871
Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43(1):27–33. https://doi.org/10.1038/ng.730
International HapMap, C (2005) A haplotype map of the human genome. Nature 437(7063):1299–1320. https://doi.org/10.1038/nature04226
Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA et al (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047):1300–1303. https://doi.org/10.1126/science.1210597
Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245–254. https://doi.org/10.1038/ng1089
Jia R, Chai P, Zhang H, Fan X (2017) Novel insights into chromosomal conformations in cancer. Mol Cancer 16(1):173. https://doi.org/10.1186/s12943-017-0741-5
John Clotaire DZ, Zhang B, Wei N, Gao R, Zhao F, Wang Y et al (2016) MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells. Biochem Biophys Res Commun 472(1):194–200. https://doi.org/10.1016/j.bbrc.2016.02.093
John S, Sabo PJ, Thurman RE, Sung MH, Biddie SC, Johnson TA et al (2011) Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet 43(3):264–268. https://doi.org/10.1038/ng.759
Johnsen JI, Segerstrom L, Orrego A, Elfman L, Henriksson M, Kagedal B et al (2008) Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Oncogene 27(20):2910–2922. https://doi.org/10.1038/sj.onc.1210938
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120(5):635–647. https://doi.org/10.1016/j.cell.2005.01.014
Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3(6):415–428. https://doi.org/10.1038/nrg816
Jones PA, Liang G (2009) Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 10(11):805–811. https://doi.org/10.1038/nrg2651
Kang L, Liu X, Gong Z, Zheng H, Wang J, Li Y et al (2015) Genome-wide identification of RNA editing in hepatocellular carcinoma. Genomics 105(2):76–82. https://doi.org/10.1016/j.ygeno.2014.11.005
Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO et al (2010) The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468(7327):1105–1109. https://doi.org/10.1038/nature09590
Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K (2007a) RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep 8(8):763–769. https://doi.org/10.1038/sj.embor.7401011
Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K (2007b) Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315(5815):1137–1140. https://doi.org/10.1126/science.1138050
Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22(3):165–173. https://doi.org/10.1016/j.tig.2006.01.003
Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA et al (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 100(20):11606–11611. https://doi.org/10.1073/pnas.1933744100
Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6(2):185–195. https://doi.org/10.1016/j.ccr.2004.07.008
Kornberg RD (1974) Chromatin structure: a repeating unit of histones and DNA. Science 184(4139):868–871
Kosak ST, Groudine M (2004) Form follows function: the genomic organization of cellular differentiation. Genes Dev 18(12):1371–1384. https://doi.org/10.1101/gad.1209304
Kouzarides T (2007a) Chromatin modifications and their function. Cell 128(4):693–705. https://doi.org/10.1016/j.cell.2007.02.005
Kouzarides T (2007b) SnapShot: histone-modifying enzymes. Cell 128(4):802. https://doi.org/10.1016/j.cell.2007.02.018
Laddha SV, Nayak S, Paul D, Reddy R, Sharma C, Jha P et al (2013) Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers. Biol Direct 8:10. https://doi.org/10.1186/1745-6150-8-10
Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V (2005) From the Cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A 102(33):11651–11656. https://doi.org/10.1073/pnas.0505575102
Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD (1984) Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 76(5):827–841
LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62(15):4499–4506
Lee AR, Che N, Lovnicki JM, Dong X (2018) Development of neuroendocrine prostate cancers by the Ser/Arg repetitive matrix 4-mediated RNA splicing network. Front Oncol 8:93. https://doi.org/10.3389/fonc.2018.00093
Li J, Huang H, Sun L, Yang M, Pan C, Chen W et al (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15(12):3998–4008. https://doi.org/10.1158/1078-0432.CCR-08-3053
Li G, Fullwood MJ, Xu H, Mulawadi FH, Velkov S, Vega V et al (2010) ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing. Genome Biol 11(2):R22. https://doi.org/10.1186/gb-2010-11-2-r22
Li M, Wang IX, Li Y, Bruzel A, Richards AL, Toung JM, Cheung VG (2011) Widespread RNA and DNA sequence differences in the human transcriptome. Science 333(6038):53–58. https://doi.org/10.1126/science.1207018
Li Y, Donmez N, Sahinalp C, Xie N, Wang Y, Xue H et al (2017) SRRM4 drives neuroendocrine transdifferentiation of prostate adenocarcinoma under androgen receptor pathway inhibition. Eur Urol 71(1):68–78. https://doi.org/10.1016/j.eururo.2016.04.028
Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK et al (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 102(16):5814–5819. https://doi.org/10.1073/pnas.0402870102
Lieberman-Aiden E, Van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A et al (2009) Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326(5950):289–293. https://doi.org/10.1126/science.1181369
Lister R, O'Malley RC, Tonti-Filippini J, Gregory BD, Berry CC, Millar AH, Ecker JR (2008) Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133(3):523–536. https://doi.org/10.1016/j.cell.2008.03.029
Litchfield K, Levy M, Orlando G, Loveday C, Law PJ, Migliorini G et al (2017) Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor. Nat Genet 49(7):1133–1140. https://doi.org/10.1038/ng.3896
Loidl P (1994) Histone acetylation: facts and questions. Chromosoma 103(7):441–449
Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27(31):4373–4379. https://doi.org/10.1038/onc.2008.72
Luger K, Richmond TJ (1998) The histone tails of the nucleosome. Curr Opin Genet Dev 8(2):140–146
Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389(6648):251–260. https://doi.org/10.1038/38444
Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML et al (2001) Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 61(12):4683–4688
Luo H, Fang S, Sun L, Liu Z, Zhao Y (2017) Comprehensive characterization of the RNA editomes in cancer development and progression. Front Genet 8:230. https://doi.org/10.3389/fgene.2017.00230
Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W et al (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132(6):958–970. https://doi.org/10.1016/j.cell.2008.01.018
Ma G, Liu H, Hua Q, Wang M, Du M, Lin Y et al (2017) KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome. Mol Cancer 16(1):46. https://doi.org/10.1186/s12943-017-0613-z
Maas S, Patt S, Schrey M, Rich A (2001) Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A 98(25):14687–14692. https://doi.org/10.1073/pnas.251531398
Maas S, Kawahara Y, Tamburro KM, Nishikura K (2006) A-to-I RNA editing and human disease. RNA Biol 3(1):1–9
Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA et al (2001) Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61(15):5692–5696
Malta TM, de Souza CF, Sabedot TS, Silva TC, Mosella MS, Kalkanis SN et al (2018) Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro-Oncology 20(5):608–620. https://doi.org/10.1093/neuonc/nox183
Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK (2001) Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1(3):194–202. https://doi.org/10.1038/35106079
Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J (2011) Epigenetic mechanisms in Alzheimer’s disease. Neurobiol Aging 32(7):1161–1180. https://doi.org/10.1016/j.neurobiolaging.2010.08.017
McGill MA, McGlade CJ (2003) Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem 278(25):23196–23203. https://doi.org/10.1074/jbc.M302827200
Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ et al (2018) Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science 359(6377):801–806. https://doi.org/10.1126/science.aan5951
Misquitta-Ali CM, Cheng E, O'Hanlon D, Liu N, McGlade CJ, Tsao MS, Blencowe BJ (2011) Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Mol Cell Biol 31(1):138–150. https://doi.org/10.1128/MCB.00709-10
Misteli T (2007) Beyond the sequence: cellular organization of genome function. Cell 128(4):787–800. https://doi.org/10.1016/j.cell.2007.01.028
Modregger J, Schmidt AA, Ritter B, Huttner WB, Plomann M (2003) Characterization of Endophilin B1b, a brain-specific membrane-associated lysophosphatidic acid acyl transferase with properties distinct from endophilin A1. J Biol Chem 278(6):4160–4167. https://doi.org/10.1074/jbc.M208568200
Morey L, Brenner C, Fazi F, Villa R, Gutierrez A, Buschbeck M et al (2008) MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks. Mol Cell Biol 28(19):5912–5923. https://doi.org/10.1128/MCB.00467-08
Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5(7):621–628. https://doi.org/10.1038/nmeth.1226
Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, Snyder M (2008) The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320(5881):1344–1349. https://doi.org/10.1126/science.1158441
Nayak S, Aich M, Kumar A, Sengupta S, Bajad P, Dhapola P et al (2018) Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma. Sci Rep 8(1):7673. https://doi.org/10.1038/s41598-018-26000-8
Nishikura K (2010) Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79:321–349. https://doi.org/10.1146/annurev-biochem-060208-105251
Niwa H (2007) How is pluripotency determined and maintained? Development 134(4):635–646. https://doi.org/10.1242/dev.02787
Noll M (1974) Internal structure of the chromatin subunit. Nucleic Acids Res 1(11):1573–1578
Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N et al (2012) Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 485(7398):381–385. https://doi.org/10.1038/nature11049
Norris EJ, Jones WD, Surleac MD, Petrescu AJ, Destephanis D, Zhang Q et al (2018) Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1. Gynecol Oncol Rep 23:41–44. https://doi.org/10.1016/j.gore.2018.01.005
Norton VG, Imai BS, Yau P, Bradbury EM (1989) Histone acetylation reduces nucleosome core particle linking number change. Cell 57(3):449–457
Novikov L, Park JW, Chen H, Klerman H, Jalloh AS, Gamble MJ (2011) QKI-mediated alternative splicing of the histone variant MacroH2A1 regulates cancer cell proliferation. Mol Cell Biol 31(20):4244–4255. https://doi.org/10.1128/MCB.05244-11
Nowak SJ, Corces VG (2004) Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20(4):214–220. https://doi.org/10.1016/j.tig.2004.02.007
Okita Y, Kimura M, Xie R, Chen C, Shen LT, Kojima Y et al (2017) The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB. Sci Signal 10(474). https://doi.org/10.1126/scisignal.aak9397
Olive V, Jiang I, He L (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42(8):1348–1354. https://doi.org/10.1016/j.biocel.2010.03.004
Oltean S, Bates DO (2014) Hallmarks of alternative splicing in cancer. Oncogene 33(46):5311–5318. https://doi.org/10.1038/onc.2013.533
Ong CT, Corces VG (2014) CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet 15(4):234–246. https://doi.org/10.1038/nrg3663
Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L et al (2010) Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 24(1):105–112
Parker BC, Zhang W (2013) Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment. Chin J Cancer 32(11):594–603. https://doi.org/10.5732/cjc.013.10178
Paul D, Sinha AN, Ray A, Lal M, Nayak S, Sharma A et al (2017) A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme. Sci Rep 7(1):2466. https://doi.org/10.1038/s41598-017-02397-6
Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S et al (2007) Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 17(11):1586–1595. https://doi.org/10.1101/gr.6493107
Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA et al (2015) Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep 13(2):267–276. https://doi.org/10.1016/j.celrep.2015.08.080
Pedersen MT, Helin K (2010) Histone demethylases in development and disease. Trends Cell Biol 20(11):662–671. https://doi.org/10.1016/j.tcb.2010.08.011
Peng Y, Dai Y, Hitchcock C, Yang X, Kassis ES, Liu L et al (2013) Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proc Natl Acad Sci U S A 110(37):15043–15048. https://doi.org/10.1073/pnas.1307107110
Pietersen AM, Horlings HM, Hauptmann M, Langerod A, Ajouaou A, Cornelissen-Steijger P et al (2008) EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Breast Cancer Res 10(6):R109. https://doi.org/10.1186/bcr2214
Pihan GA (2013) Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer. Front Oncol 3:277. https://doi.org/10.3389/fonc.2013.00277
Quina AS, Buschbeck M, Di Croce L (2006) Chromatin structure and epigenetics. Biochem Pharmacol 72(11):1563–1569. https://doi.org/10.1016/j.bcp.2006.06.016
Radman-Livaja M, Rando OJ (2010) Nucleosome positioning: how is it established, and why does it matter? Dev Biol 339(2):258–266. https://doi.org/10.1016/j.ydbio.2009.06.012
Reisman D, Glaros S, Thompson EA (2009) The SWI/SNF complex and cancer. Oncogene 28(14):1653–1668. https://doi.org/10.1038/onc.2009.4
Richmond TJ, Davey CA (2003) The structure of DNA in the nucleosome core. Nature 423(6936):145–150. https://doi.org/10.1038/nature01595
Rickman DS, Soong TD, Moss B, Mosquera JM, Dlabal J, Terry S et al (2012) Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci U S A 109(23):9083–9088. https://doi.org/10.1073/pnas.1112570109
Roix JJ, McQueen PG, Munson PJ, Parada LA, Misteli T (2003) Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet 34(3):287–291. https://doi.org/10.1038/ng1177
Roush S, Slack FJ (2008) The let-7 family of microRNAs. Trends Cell Biol 18(10):505–516. https://doi.org/10.1016/j.tcb.2008.07.007
Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243(5405):290–293
Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC et al (2018) Oncogenic signaling pathways in the cancer genome Atlas. Cell 173(2):321–337. e310. https://doi.org/10.1016/j.cell.2018.03.035
Sanmartin E, Yanez Y, Fornes-Ferrer V, Zugaza JL, Canete A, Castel V, Font de Mora J (2017) TIAM1 variants improve clinical outcome in neuroblastoma. Oncotarget 8(28):45286–45297. https://doi.org/10.18632/oncotarget.16787
Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(5235):467–470
Schramm A, Koster J, Marschall T, Martin M, Schwermer M, Fielitz K et al (2013) Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma. Int J Cancer 132(3):E106–E115. https://doi.org/10.1002/ijc.27787
Schuster-Bockler B, Lehner B (2012) Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488(7412):504–507. https://doi.org/10.1038/nature11273
Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226–231. https://doi.org/10.1038/nature10833
Seeburg PH, Hartner J (2003) Regulation of ion channel/neurotransmitter receptor function by RNA editing. Curr Opin Neurobiol 13(3):279–283
Seligson DB, Horvath S, McBrian MA, Mah V, Yu H, Tze S et al (2009) Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 174(5):1619–1628. https://doi.org/10.2353/ajpath.2009.080874
Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB et al (2012) Recurrent R-spondin fusions in colon cancer. Nature 488(7413):660–664. https://doi.org/10.1038/nature11282
Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31(1):27–36. https://doi.org/10.1093/carcin/bgp220
Sharma A, Ansari AH, Kumari R, Pandey R, Rehman R, Mehani B et al (2016) Human brain harbors single nucleotide somatic variations in functionally relevant genes possibly mediated by oxidative stress. F1000Res 5:2520. https://doi.org/10.12688/f1000research.9495.3
Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA et al (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119(7):941–953. https://doi.org/10.1016/j.cell.2004.12.012
Shi YX, Wang Y, Li X, Zhang W, Zhou HH, Yin JY, Liu ZQ (2017) Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer. BMC Genomics 18(1):901. https://doi.org/10.1186/s12864-017-4223-3
Simonis M, de Laat W (2008) FISH-eyed and genome-wide views on the spatial organisation of gene expression. Biochim Biophys Acta 1783(11):2052–2060. https://doi.org/10.1016/j.bbamcr.2008.07.020
Simonis M, Klous P, Splinter E, Moshkin Y, Willemsen R, de Wit E et al (2006) Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat Genet 38(11):1348–1354. https://doi.org/10.1038/ng1896
Sims RJ 3rd, Nishioka K, Reinberg D (2003) Histone lysine methylation: a signature for chromatin function. Trends Genet 19(11):629–639. https://doi.org/10.1016/j.tig.2003.09.007
Smith AP, Hoek K, Becker D (2005) Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol Ther 4(9):1018–1029
Song L, Zhang Z, Grasfeder LL, Boyle AP, Giresi PG, Lee BK et al (2011) Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res 21(10):1757–1767. https://doi.org/10.1101/gr.121541.111
Song JS, Kim YS, Kim DK, Park SI, Jang SJ (2012) Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients. Pathol Int 62(3):182–190. https://doi.org/10.1111/j.1440-1827.2011.02776.x
Song C, Zhang L, Wang J, Huang Z, Li X, Wu M et al (2016) High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer. Sci Rep 6:24502. https://doi.org/10.1038/srep24502
Splinter E, de Wit E, Nora EP, Klous P, van de Werken HJ, Zhu Y et al (2011) The inactive X chromosome adopts a unique three-dimensional conformation that is dependent on Xist RNA. Genes Dev 25(13):1371–1383. https://doi.org/10.1101/gad.633311
Sporn JC, Jung B (2012) Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer. Am J Pathol 180(6):2516–2526. https://doi.org/10.1016/j.ajpath.2012.02.027
Sporn JC, Kustatscher G, Hothorn T, Collado M, Serrano M, Muley T et al (2009) Histone macroH2A isoforms predict the risk of lung cancer recurrence. Oncogene 28(38):3423–3428. https://doi.org/10.1038/onc.2009.26
Stirzaker C, Taberlay PC, Statham AL, Clark SJ (2014) Mining cancer methylomes: prospects and challenges. Trends Genet 30(2):75–84. https://doi.org/10.1016/j.tig.2013.11.004
Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458(7239):719–724. https://doi.org/10.1038/nature07943
Sung MH, Guertin MJ, Baek S, Hager GL (2014) DNase footprint signatures are dictated by factor dynamics and DNA sequence. Mol Cell 56(2):275–285. https://doi.org/10.1016/j.molcel.2014.08.016
Svotelis A, Gevry N, Gaudreau L (2009) Regulation of gene expression and cellular proliferation by histone H2A.Z. Biochem Cell Biol 87(1):179–188. https://doi.org/10.1139/O08-138
Svotelis A, Gevry N, Grondin G, Gaudreau L (2010) H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle 9(2):364–370. https://doi.org/10.4161/cc.9.2.10465
Szenker E, Ray-Gallet D, Almouzni G (2011) The double face of the histone variant H3.3. Cell Res 21(3):421–434. https://doi.org/10.1038/cr.2011.14
Szyf M (2016) The elusive role of 5′-hydroxymethylcytosine. Epigenomics 8(11):1539–1551. https://doi.org/10.2217/epi-2016-0076
Taberlay PC, Achinger-Kawecka J, Lun AT, Buske FA, Sabir K, Gould CM et al (2016) Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations. Genome Res 26(6):719–731. https://doi.org/10.1101/gr.201517.115
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929):930–935. https://doi.org/10.1126/science.1170116
Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y et al (2007) Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 9(10):1142–1151. https://doi.org/10.1038/ncb1634
Takashima Y, Sasaki Y, Hayano A, Homma J, Fukai J, Iwadate Y et al (2018) Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma. Oncotarget 9(44):27471–27486. https://doi.org/10.18632/oncotarget.25463
Thomas A, Mahantshetty U, Kannan S, Deodhar K, Shrivastava SK, Kumar-Sinha C, Mulherkar R (2013) Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Med 2(6):836–848. https://doi.org/10.1002/cam4.152
Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E et al (2012) The accessible chromatin landscape of the human genome. Nature 489(7414):75–82. https://doi.org/10.1038/nature11232
Tirado-Magallanes R, Rebbani K, Lim R, Pradhan S, Benoukraf T (2017) Whole genome DNA methylation: beyond genes silencing. Oncotarget 8(3):5629–5637. https://doi.org/10.18632/oncotarget.13562
Tiwari VK, McGarvey KM, Licchesi JD, Ohm JE, Herman JG, Schubeler D, Baylin SB (2008) PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol 6(12):2911–2927. https://doi.org/10.1371/journal.pbio.0060306
Toledo RA, Garralda E, Mitsi M, Pons T, Monsech J, Vega E et al (2018) Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of antiangiogenic therapies. Clin Cancer Res 24(15):3550–3559. https://doi.org/10.1158/1078-0432.CCR-18-0103
Tomaselli S, Galeano F, Alon S, Raho S, Galardi S, Polito VA et al (2015) Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma. Genome Biol 16:5. https://doi.org/10.1186/s13059-014-0575-z
Tripathi M, Nandana S, Yamashita H, Ganesan R, Kirchhofer D, Quaranta V (2008) Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J Biol Chem 283(45):30576–30584. https://doi.org/10.1074/jbc.M802312200
Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y (2006) Histone demethylation by a family of JmjC domain-containing proteins. Nature 439(7078):811–816. https://doi.org/10.1038/nature04433
Turc-Carel C, Dal Cin P, Limon J, Rao U, Li FP, Corson JM et al (1987) Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A 84(7):1981–1985
van Berkum NL, Lieberman-Aiden E, Williams L, Imakaev M, Gnirke A, Mirny LA et al (2010) Hi-C: a method to study the three-dimensional architecture of genomes. J Vis Exp 39. https://doi.org/10.3791/1869
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419(6907):624–629. https://doi.org/10.1038/nature01075
Verger A, Crossley M (2004) Chromatin modifiers in transcription and DNA repair. Cell Mol Life Sci 61(17):2154–2162. https://doi.org/10.1007/s00018-004-4176-y
Vidal E, Sayols S, Moran S, Guillaumet-Adkins A, Schroeder MP, Royo R et al (2017) A DNA methylation map of human cancer at single base-pair resolution. Oncogene 36(40):5648–5657. https://doi.org/10.1038/onc.2017.176
Vietri Rudan M, Barrington C, Henderson S, Ernst C, Odom DT, Tanay A, Hadjur S (2015) Comparative Hi-C reveals that CTCF underlies evolution of chromosomal domain architecture. Cell Rep 10(8):1297–1309. https://doi.org/10.1016/j.celrep.2015.02.004
Waldman T, Kinzler KW, Vogelstein B (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55(22):5187–5190
Wang DB, Uo T, Kinoshita C, Sopher BL, Lee RJ, Murphy SP et al (2014) Bax interacting factor-1 promotes survival and mitochondrial elongation in neurons. J Neurosci 34(7):2674–2683. https://doi.org/10.1523/JNEUROSCI.4074-13.2014
Wang Y, Xu X, Yu S, Jeong KJ, Zhou Z, Han L et al (2017) Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. Genome Res 27(7):1112–1125. https://doi.org/10.1101/gr.219741.116
Wei J, van der Wekken AJ, Saber A, Terpstra MM, Schuuring E, Timens W et al (2018) Mutations in EMT-related genes in ALK positive crizotinib resistant non-small cell lung cancers. Cancers (Basel) 10(1). https://doi.org/10.3390/cancers10010010
Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38(7):787–793. https://doi.org/10.1038/ng1834
Westhoff B, Colaluca IN, D'Ario G, Donzelli M, Tosoni D, Volorio S et al (2009) Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A 106(52):22293–22298. https://doi.org/10.1073/pnas.0907781106
Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z et al (2006) Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125(3):467–481. https://doi.org/10.1016/j.cell.2006.03.028
Winter DR, Song L, Mukherjee S, Furey TS, Crawford GE (2013) DNase-seq predicts regions of rotational nucleosome stability across diverse human cell types. Genome Res 23(7):1118–1129. https://doi.org/10.1101/gr.150482.112
Witcher M, Emerson BM (2009) Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 34(3):271–284. https://doi.org/10.1016/j.molcel.2009.04.001
Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251–253. https://doi.org/10.1038/ng.1102
Xi R, Kim TM, Park PJ (2010) Detecting structural variations in the human genome using next generation sequencing. Brief Funct Genomics 9(5–6):405–415. https://doi.org/10.1093/bfgp/elq025
Xiong Q, Zhong Q, Zhang J, Yang M, Li C, Zheng P et al (2012) Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics. J Proteome Res 11(4):2078–2090. https://doi.org/10.1021/pr201079y
Xu J, Lin DI (2018) Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas. PLoS One 13(7):e0199688. https://doi.org/10.1371/journal.pone.0199688
Yan W, Zhang W, You G, Zhang J, Han L, Bao Z et al (2012) Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro-Oncology 14(12):1432–1440. https://doi.org/10.1093/neuonc/nos263
Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R, Nishikura K (2006) Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 13(1):13–21. https://doi.org/10.1038/nsmb1041
Yang CC, Buck MJ, Chen MH, Chen YF, Lan HC, Chen JJ et al (2013) Discovering chromatin motifs using FAIRE sequencing and the human diploid genome. BMC Genomics 14:310. https://doi.org/10.1186/1471-2164-14-310
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L et al (2012) MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 31(41):4421–4433. https://doi.org/10.1038/onc.2011.629
Yoon JK, Lee JS (2012) Cellular signaling and biological functions of R-spondins. Cell Signal 24(2):369–377. https://doi.org/10.1016/j.cellsig.2011.09.023
Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW, Zhang JW (2006) Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun 349(1):59–68. https://doi.org/10.1016/j.bbrc.2006.07.207
Zeitz MJ, Ay F, Heidmann JD, Lerner PL, Noble WS, Steelman BN, Hoffman AR (2013) Genomic interaction profiles in breast cancer reveal altered chromatin architecture. PLoS One 8(9):e73974. https://doi.org/10.1371/journal.pone.0073974
Zhang Y (2003) Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev 17(22):2733–2740. https://doi.org/10.1101/gad.1156403
Zhang Z, Pugh BF (2011) High-resolution genome-wide mapping of the primary structure of chromatin. Cell 144(2):175–186. https://doi.org/10.1016/j.cell.2011.01.003
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27(4):1019–1026. https://doi.org/10.3892/or.2012.1645
Zhao Z, Tavoosidana G, Sjolinder M, Gondor A, Mariano P, Wang S et al (2006) Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat Genet 38(11):1341–1347. https://doi.org/10.1038/ng1891
Zhao JJ, Chu ZB, Hu Y, Lin J, Wang Z, Jiang M et al (2015) Targeting the miR-221-222/PUMA/BAK/BAX pathway abrogates dexamethasone resistance in multiple myeloma. Cancer Res 75(20):4384–4397. https://doi.org/10.1158/0008-5472.CAN-15-0457
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lal, M., Paul, D., Nayak, S., Mukhopadhyay, A. (2019). Genomic Applications and Insights in Unravelling Cancer Signalling Pathways. In: Bose, K., Chaudhari, P. (eds) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Springer, Singapore. https://doi.org/10.1007/978-981-32-9816-3_18
Download citation
DOI: https://doi.org/10.1007/978-981-32-9816-3_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9815-6
Online ISBN: 978-981-32-9816-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)